(Q35600960)

9 August 2017

title

Integration of antiretroviral therapy with tuberculosis treatment (English)

1 reference

9 August 2017

main subject

anti-retroviral agent

0 references

0 references

14

Quarraisha Abdool Karim

0 references

Tanuja N. Gengiah

Tanuja Gengiah

7

0 references

Andrew Gray

Andrew L Gray

6

0 references

Kogieleum Naidoo

Kogieleum Naidoo

2

0 references

Anneke C. Grobler

Anneke Grobler

3

0 references

Salim Abdool Karim

Salim S Abdool Karim

1

0 references

Nesri Padayatchi

Nesri Padayatchi

4

0 references

Cheryl Baxter

5

Cheryl Baxter

1 reference

9 August 2017

12

Wafaa M El-Sadr

1 reference

9 August 2017

11

Gonasagrie Nair

1 reference

9 August 2017

13

Gerald Friedland

1 reference

9 August 2017

Santhanalakshmi Gengiah

8

Santhanalakshmi Gengiah

1 reference

9 August 2017

9

Anushka Naidoo

1 reference

9 August 2017

10

Niraksha Jithoo

1 reference

9 August 2017

language of work or name

English

0 references

publication date

1 October 2011

1 reference

The New England Journal of Medicine

9 August 2017

published in

1 reference

9 August 2017

volume

365

1 reference

9 August 2017

issue

16

1 reference

9 August 2017

page(s)

1492-1501

1 reference

Timing of initiation of antiretroviral drugs during tuberculosis therapy

9 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3233684

Early versus delayed fixed dose combination abacavir/lamivudine/zidovudine in patients with HIV and tuberculosis in Tanzania

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3233684

Effect of rifampicin-based antitubercular therapy and the cytochrome P450 2B6 516G>T polymorphism on efavirenz concentrations in adults in South Africa

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3233684

Adverse events to antituberculosis therapy: influence of HIV and antiretroviral drugs

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3233684

Pulmonary tuberculosis in AIDS patients: transient chest radiographic worsening after initiation of antiretroviral therapy

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3233684

Paradoxical reactions in HIV and pulmonary TB.

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3233684

A study of TB-associated immune reconstitution inflammatory syndrome using the consensus case-definition.

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3233684

Efavirenz and nevirapine interactions with rifampicin: resolving the dilemmas?

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3233684

Outcomes in HIV-infected patients on antiretroviral therapy with tuberculosis

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3233684

Tuberculosis-associated immune reconstitution disease: incidence, risk factors and impact in an antiretroviral treatment service in South Africa

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3233684

Treatment of tuberculosis in HIV-infected persons in the era of highly active antiretroviral therapy.

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3233684

Changing Clinical Presentation and Survival in HIV-Associated Tuberculosis After Highly Active Antiretroviral Therapy

26 September 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22010915

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1056/NEJMOA1014181

1 reference

9 August 2017

1 reference

9 August 2017

1 reference